104 related articles for article (PubMed ID: 10428371)
1. Design and synthesis of thrombin receptor-derived nonpeptide mimetics utilizing a piperazine scaffold.
Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Smith J; Mavromoustakos T; Saifeddine M; Moore G; Hollenberg M; Matsoukas J
Bioorg Med Chem; 1999 Jun; 7(6):1033-41. PubMed ID: 10428371
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and modeling of novel cyclic thrombin receptor-derived peptide analogues of the Ser42-Phe-Leu-Leu-Arg46 motif sequence with fixed conformations of pharmacophoric groups: importance of a Phe/Arg/NH2 cluster for receptor activation and implications in the design of nonpeptide thrombin receptor mimetics.
Alexopoulos K; Panagiotopoulos D; Mavromoustakos T; Fatseas P; Paredes-Carbajal MC; Mascher D; Mihailescu S; Matsoukas J
J Med Chem; 2001 Feb; 44(3):328-39. PubMed ID: 11462974
[TBL] [Abstract][Full Text] [Related]
4. A comparative SAR study of thrombin receptor derived non peptide mimetics: importance of phenyl/guanidino proximity for activity.
Alexopoulos K; Matsoukas J; Tselios T; Roumelioti P; Mavromoustakos T; Holada K
Amino Acids; 1998; 15(3):211-20. PubMed ID: 9871500
[TBL] [Abstract][Full Text] [Related]
5. 'Tethered ligand' derived pentapeptide agonists of thrombin receptor: a study of side chain requirements for human platelet activation and GTPase stimulation.
Natarajan S; Riexinger D; Peluso M; Seiler SM
Int J Pept Protein Res; 1995 Feb; 45(2):145-51. PubMed ID: 7782162
[TBL] [Abstract][Full Text] [Related]
6. Modulation of angiogenesis and progelatinase a by thrombin receptor mimetics and antagonists.
Maragoudakis ME; Kraniti N; Giannopoulou E; Alexopoulos K; Matsoukas J
Endothelium; 2001; 8(3):195-205. PubMed ID: 11824472
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiaggregatory activity of RGD-peptidomimetics based on 4-oxo-4-(piperazine-1-yl)butyric acid as Arg-mimetic.
Andronati SA; Krysko AA; Kabanov VM; Kabanova TA; Karaseva TL; Chugunov BM; Meshkova SB; Topilova ZM
Acta Pol Pharm; 2003; 60(5):375-81. PubMed ID: 15005421
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of thrombin and SFLLR-peptide stimulation of platelet aggregation, phospholipase A2 and Na+/H+ exchange by a thrombin receptor antagonist.
Seiler SM; Peluso M; Michel IM; Goldenberg H; Fenton JW; Riexinger D; Natarajan S
Biochem Pharmacol; 1995 Feb; 49(4):519-28. PubMed ID: 7872957
[TBL] [Abstract][Full Text] [Related]
9. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides.
Hollenberg MD; Saifeddine M; al-Ani B; Kawabata A
Can J Physiol Pharmacol; 1997 Jul; 75(7):832-41. PubMed ID: 9315351
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design of residue 1 analogs of the direct thrombin inhibitor pentapeptide FM 19.
Girnys EA; Sobczyk-Kojiro K; Mosberg HI
Chem Biol Drug Des; 2010 Jan; 75(1):35-9. PubMed ID: 19954432
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of non-peptide PAR1 thrombin receptor antagonists based on small bifunctional templates: arginine and phenylalanine side chain groups are keys for receptor activity.
Androutsou ME; Saifeddine M; Hollenberg MD; Matsoukas J; Agelis G
Amino Acids; 2010 Apr; 38(4):985-90. PubMed ID: 19484400
[TBL] [Abstract][Full Text] [Related]
12. Edge-to-face CH/pi interaction between ligand Phe-phenyl and receptor aromatic group in the thrombin receptor activation.
Matsushima A; Fujita T; Nose T; Shimohigashi Y
J Biochem; 2000 Aug; 128(2):225-32. PubMed ID: 10920258
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity studies of the thrombin receptor activating peptide.
Sabo T; Gurwitz D; Motola L; Brodt P; Barak R; Elhanaty E
Biochem Biophys Res Commun; 1992 Oct; 188(2):604-10. PubMed ID: 1332704
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives.
Lin KW; Fang SC; Hung CF; Shieh BJ; Yang SC; Teng CM; Lin CN
Arch Pharm (Weinheim); 2009 Jan; 342(1):19-26. PubMed ID: 19035386
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of some 1,3-dihydro-2H-3-benzazepin-2-ones with a piperazine moiety as bradycardic agents.
Liang HY; Zhang DQ; Yue Y; Shi Z; Zhao SY
Arch Pharm (Weinheim); 2010 Feb; 343(2):114-9. PubMed ID: 20108265
[TBL] [Abstract][Full Text] [Related]
16. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
17. Peptides and pseudopeptides incorporating D-Phe-Pro-Arg and Arg-Gly-Asp lead sequences as potential antithrombotic agents.
Ilas J; Hudecz F; Süli-Vargha H; Kikelj D
J Pept Sci; 2008 Aug; 14(8):946-53. PubMed ID: 18383437
[TBL] [Abstract][Full Text] [Related]
18. Characterization of in vitro and in vivo platelet responses to thrombin and thrombin receptor-activating peptides in guinea pigs.
Chiu PJ; Tetzloff GG; Foster C; Chintala M; Sybertz EJ
Eur J Pharmacol; 1997 Feb; 321(1):129-35. PubMed ID: 9083795
[TBL] [Abstract][Full Text] [Related]
19. Vascular actions of thrombin receptor-derived polypeptides: structure-activity profiles for contractile and relaxant effects in rat aorta.
Laniyonu AA; Hollenberg MD
Br J Pharmacol; 1995 Apr; 114(8):1680-6. PubMed ID: 7541284
[TBL] [Abstract][Full Text] [Related]
20. In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist.
Kato Y; Kita Y; Nishio M; Hirasawa Y; Ito K; Yamanaka T; Motoyama Y; Seki J
Eur J Pharmacol; 1999 Nov; 384(2-3):197-202. PubMed ID: 10611442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
